303
Views
12
CrossRef citations to date
0
Altmetric
Articles

Encapsulation of ciprofloxacin, sparfloxacin, and ofloxacin drugs with α- and β-cyclodextrins: spectral and molecular modelling studies

, &
Pages 193-212 | Received 15 May 2015, Accepted 04 Jul 2015, Published online: 10 Aug 2015

References

  • Sivasankar T, Antony Muthu Prabhu A, Karthick M, et al. Encapsulation of vanillylamine by native and modified β-CD cavity: spectral and computational studies. J Mol Struc. 2012;1028:57–67. doi:10.1016/j.molstruc.2012.06.025.
  • Antony Muthu Prabhu A, Vk S, Rajendiran N. Excimer formation in inclusion complexes of β-CD with salbutamol, sotalol and atenolol: spectral and molecular modeling studies. Spectrochim Acta A. 2012;96:95–107. doi:10.1016/j.saa.2012.04.044.
  • Antony Muthu Prabhu A, Sankaranarayanan RK, Venkatesh G, et al. Dual fluorescence of fast blue RR fast violet B: effect of solvents, cyclodextrin complexation. J Phys Chem B. 2012;166:9061–9074. doi:10.1021/jp302162g.
  • Rajendiran N, Mohandoss T, Thulasidhasan J. Excimer emission in norepinephrine and epinephrine drugs with α- and β-cyclodextrins: spectral and molecular modeling studies. J Fluores. 2014;24:1003–1014. doi:10.1007/s10895-014-1361-8.
  • Rajendiran N, Venkatesh G. Micrometer size rod like structure formed by secondary self assembly of omeprazole inclusion complexes with α- and β-cyclodextrins. Spectrochim Acta A. 2015;137:832–840. doi:10.1016/j.saa.2014.08.074.
  • Rajendiran N, Sankaranarayanan RK, Venkatesh G. Excimer emission in inclusion complexes of dibenzofuran and 5-dibenzosuberenone with α- and β-cyclodextrins. Bull Chem Soc Japan. 2014;87:797–808. doi:10.1246/bcsj.20140057.
  • Rajendiran N, Sankaranarayanan RK, Saravanan J. A study of supramolecular host–guest interaction of dothiepin and doxepin drugs with cyclodextrin macrocycles. J Mol Struct. 2014;1067:252–260. doi:10.1016/j.molstruc.2014.03.051.
  • Venkatesh G, Sivasankar T, Karthick M, et al. Inclusion complexes of sulphanilamide drugs and β-CD: a theoretical approach. J Incl Phenom Macrocycl Chem. 2013;77:309–318. doi:10.1007/s10847-012-0248-z.
  • Rajendiran N, Venkatesh G. Inclusion complexation of 4,4ʹ-dihydroxy benzophenone and 4-hydroxy benzophenone with α- and β-CD. Supramolecular Chem. 2014;26:783–795. doi:10.1080/10610278.2013.873125.
  • Dura´n Meras I, Munoz de la Pena A, Salinas F, et al. Spectrofluorimetric determination of nalidixic acid based on host–guest complexation with γ-cyclodextrin. Analyst. 1994;119:1215–1219. doi:10.1039/an9941901215.
  • Vincent JB, Sokolowski AD, Nguyen TV, et al. A family of single-isomer chiral resolving agents for capillary electrophoresis. 1. Heptakis (2,3-diacetyl-6-sulfato)-β-cyclodextrin. Anal Chem. 1997;69:4226–4233. doi:10.1021/ac970252r.
  • Breslow R, Dong SD. Biomimetic reactions catalyzed by cyclodextrins and their derivatives. Chem Rev. 1998;98:1997–2012. DOI:10.1021/cr970011j.
  • Szejeli J. Cyclodextrin technology. Dordrecht: Kluwer Academic Publishers; 1998.
  • Anton Smith A, Kannan K, Manavalan R, et al. Spectrofluorimetric determination of Tramadol in formulation and biological fluids. Int J Chem Sci. 2008;6:789–799.
  • Anton Smith A, Kannan K, Manavalan R, et al. Spectrofluorimetric determination of bicalutamide in formulation & biological fluids. Asian J Chem. 2009;21:459–466.
  • Anton Smith A, Kannan K, Manavalan R, et al. Determination of bicalutamide in formulation and biological fluids based on cyclodextrin enhanced fluorescence. J Appl Chem Res. 2009;9:24–32.
  • Szathmary SO, De Coster R. Parenteral safety and use of 2- hydroxy propyl-β-cyclodextrin. Minutes Int Symp Cyclodextrins. 1990;5:525–534.
  • Szathmary SC, Seiler KU, Luhmann I, et al. Pharmacokinetic behaviour and absolute bioavailability of hydroxy propyl -β-cyclodextrin after increasing the doses of volunteers. Minutes Int Symp Cyclodextrins. 1990;5:535–540.
  • Oliphant CM, Green GM. Quinolones: a comprehensive review. Am Fam Physician. 2002;65:455–464.
  • Zhanel GG, Ennis K, Vercaigne L, et al. A critical review of the new fluoroquinolones: focus on respiratory infections. Drugs. 2002;62:13–59. doi:10.2165/00003495-200262010-00002.
  • Drlica K, Zhao X. DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol Mol Biol Rev. 1997;61:377–392.
  • Zornoza A, Martin C, Sanchez M, et al. Inclusion complexation of glisentide with α-cyclodextrins, β-cyclodextrins and γ-cyclodextrins. Int J Pharm. 1998;169:239–244. doi:10.1016/S0378-5173(98)00124-0.
  • Chao J, Li J, Meng D, et al. Preparation and study on the solid inclusion complex of sparfloxacin with HP-β-cyclodextrin. Spectrochim Acta. 2003;59:705–711. doi:10.1016/S1386-1425(02)00236-6.
  • Chao J-B, Tong H-B, Huang S-P, et al. Preparation and study on the solid inclusion complex of sparfloxacin with β-cyclodextrin. Spectrochim Acta. 2004;60:161–166. doi:10.1016/S1386-1425(03)00211-7.
  • Chao J, Meng D, Jiangsong L, et al. Preparation and study on the novel solid inclusion complex of ciprofloxacin with HP-β-cyclodextrin. Spectrochim Acta A. 2004;60:729–734. doi:10.1016/S1386-1425(03)00284-1.
  • Steiner T, Koellner GJ. Crystalline β-cyclodextrin hydrate at various humidities: fast, continuous and reversible dehydration studied by X-ray diffraction. Am Chem Soc. 1994;116:5122–5128. doi:10.1021/ja00091a014.
  • Rafati AA, Hashemianzadeh SM, Nojini ZB, et al. Theoretical study of the inclusion complexes of α- and β-cyclodextrins with decyltrimethylammonium bromide (DTAB) and tetradecyltrimethylammonium bromide (TTAB). J Mol Liq. 2007;135:153–157. doi:10.1016/j.molliq.2006.11.006.
  • Benesi HA, Hildebrand JH. A spectrophotometric investigation of the interaction of iodine with aromatic hydrocarbons. J Am Chem Soc. 1949;71:2703–2707. doi:10.1021/ja01176a030.
  • Jude Jenita M, Antony Muthu Prabhu A, Rajendiran N. Theoretical study of inclusion complexation of tricyclic antidepressant drugs with β-CD. Indian J Chem A. 2012;51A:1686–1694.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.